The project starts in September 2020 in the laboratories of the Regina Elena Institute in Rome with funding from NAnA for a grant won by Dr. Gabriele Loiudice to work on the project “Identification and study of the impact of genetic susceptibility variants in adolescent acute myeloid leukemia (AML).” The research is the result of a collaboration between Dr. Maurizio Fanciulli ‘s group from the Department of Research, Diagnosis and Innovative Technologies atIRCCS Regina Elena National Cancer Institute, Scientific Director Prof. Gennaro Ciliberto, and the Laboratory of Advanced Oncohematology Diagnostics at the University of Rome Tor Vergata, directed by Prof. Maria Teresa Voso. The results of the work done were published in July 2022 in the Journal of Translational Medicine, in an article that can be consulted by clicking on the image opposite.